/Investor DB

F-Prime Capital — Full Portfolio

459 tracked investments · page 1 of 3 · listed companies and verified rows first

Caribou Biosciencescariboubio.comin𝕏NASDAQ: CRBUMar 2021

Caribou Biosciences is a clinical-stage biopharmaceutical company developing CRISPR genome-editing therapies, including off-the-shelf CAR-T cell therapies for hematologic malignancies and armored cell therapies using its Cas12a chRDNA platform.

BiotechMedical DevicesBerkeley, US

Jennifer Doudna(Founder)Rachel Haurwitz(Founder)inMartin Jinek(Founder)Andrew May(Executive Officer)James Berger(Founder)

BoardJenny Rooke(Director)in

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAliment CapitalAvego BioScience CapitalIA Seed VenturesLifeSci Venture PartnersMission Bay CapitalMission Biocapital+3 more

Neumora Therapeuticsneumoratx.comin𝕏NASDAQ: NMRASeries A · Jan 2023 · $400M

Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.

BiotechDeep TechDigital HealthMedical DevicesWatertown, US

Paul L. Berns(Chairman and Chief Executive Officer)Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)

Board seatStacie Weninger· per SEC Form D

Co-investorsARCH Venture PartnersCatalio Capital Management, LPK2 HealthVenturesMercury FundPremier PartnersSoftBank Vision Fund+12 more

peerTransferNASDAQ: FLYWFeb 2020

Flywire operates a global payments platform and software company that processes high-value transactions for education, healthcare, travel, and business-to-business sectors, combining invoicing, settlement tools, and local payment methods across 240+ countries and 140+ currencies to help organizations optimize their accounts receivable functions.

Boston, US

Michael Massaro(Executive Officer, Director)Robert Orgel(President and Chief Operating Officer)Cosmin Pitigoi(Chief Financial Officer)Patrick Blanc(Chief Technology Officer)Peter Butterfield(General Counsel and Chief Compliance Officer)Mohit Kansal(Chief Payments Officer)

Board seatDavid Jegen· per SEC Form D

Co-investorsGoldman SachsKfundSpark Capital

ShouTi Inc.NASDAQ: GPCRJan 2022SEC filingmedium confidence

ShouTi Inc. is a clinical-stage biopharmaceutical company developing oral small molecule drugs targeting G-protein coupled receptors to treat chronic diseases including obesity, type 2 diabetes, and cardiovascular conditions.

BiotechSouth San Francisco, US

Raymond Stevens(Director)Ramy Farid(Director)Jessica Lifton(Director)Ting Xie(Director)Daniel Auerbach(Director)Cuiping Gu(Director)

Board seatRobert Weisskoff· per SEC Form D · $7M raise · filed Jan 2022

Co-investorsBiotechnology Value Fund

Xilio Therapeuticsxiliotx.cominNASDAQ: XLOJan 2021

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsBain Capital Life SciencesBay City CapitalM VenturesMRL Ventures FundRA CapitalRiverVest Venture Partners+9 more

Aclaris Therapeuticsaclaristx.comNASDAQ: ACRSSeries A · Oct 2012 · $21M

Aclaris develops investigational monoclonal antibodies and small-molecule inhibitors targeting immune pathways for the treatment of atopic, autoimmune, and respiratory diseases.

BiotechHealthtechMedical DevicesWayne, US

Neal Walker(Executive Officer, Director)Kamil Ali-Jackson(Executive Officer)Stuart D. Shanler(Executive Officer)inJoseph Monahan(Executive Officer)inHugh Davis(Executive Officer, Director)inJames Loerop(Executive Officer)

Co-investorsAisling CapitalAPERTURE Venture PartnersForesite CapitalRA CapitalSofinnova VenturesSofinnova Venture Partners+1 more

Adageneadagene.cominNASDAQ: ADAGJan 2020

Adagene is a clinical-stage immunotherapy company that uses computational biology and artificial intelligence to discover and design therapeutic antibodies for cancer treatment.

AI & Machine LearningBiotech

Co-investorsEight Roads VenturesGeneral AtlanticToba CapitalSequoia Capital

Adaptimmuneadaptimmune.comin𝕏OTC: ADAPYSep 2014

Adaptimmune Therapeutics is a biotechnology company, though the specific focus of their therapeutic work is not detailed on this investors and media page.

BiotechHealthtechMedical DevicesAbingdon, Oxfordshire, US

James Noble(Chief Executive Officer)Adrian Rawcliffe(Chief Executive Officer and Director)inGavin Wood(Chief Financial Officer)inWilliam Bertrand(Chief Operating Officer)inJohn Lunger(Chief Patient Supply Officer)inElliot Norry(Chief Medical Officer)in

Co-investorsAvoro Capital AdvisorsEight Roads VenturesForesite CapitalNew Enterprise Associates (NEA)Ridgeback Capital

Avalyn Pharma Incavalynpharma.cominNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera PartnersCatalio Capital Management, LPInVivium CapitalNorwest Venture PartnersPivotal Life SciencesRiverVest Venture Partners+9 more

Beam Therapeuticsbeamtx.comin𝕏NASDAQ: BEAMNov 2018

Beam Therapeutics develops gene-editing medicines, particularly base editors and precision genome editing technologies, to create lifelong cures for patients with serious genetic diseases.

BiotechDeep TechMedical DevicesCambridge, US

David R. Liu(Founder)inJ. Keith Joung(Founder)inFeng Zhang(Founder)David R. Liu, Ph.D.(Founder and Inventor)J. Keith Joung, M.D., Ph.D.(Founder and Inventor)Feng Zhang, Ph.D.(Founder and Inventor)

Co-investorsARCH Venture PartnersDreamers VCEight Roads VenturesForesite CapitalGV (Google Ventures)HongShan Capital Group+2 more

Bicara Therapeuticsbicara.comin𝕏NASDAQ: BCAXSeries B · Mar 2023 · $110M

Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors.

Ivan Hyep(Chief Financial Officer and Treasurer)inLara Meisner(Chief Legal Officer, Compliance Officer and Corporate Secretary)inDavid Raben(Chief Medical Officer)in

Co-investorsAisling CapitalEight Roads VenturesForesite CapitalPremji InvestRA CapitalRed Tree Venture+6 more

Coherus Biosciencescoherus.comin𝕏NASDAQ: CHRS

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer.

BiotechHealthtechMedical DevicesRedwood City, US

Dennis M. Lanfear(Executive Officer, Director)Denny Lanfear(Founder)inAlan C. Herman(Executive Officer)inJean-Frederic Viret, Ph.D.(Executive Officer)Peter K. Watler, Ph.D.(Executive Officer)Barbara K Finck, M.D.(Executive Officer)

Co-investorsHEALTHCARE ROYALTY PARTNERSSofinnova VenturesVenrock

Coinbasecoinbase.comin𝕏Nasdaq: COIN

Coinbase is a cryptocurrency exchange platform that offers trading, custody, and financial services for cryptocurrencies, stocks, derivatives, and prediction markets to consumers, institutions, and developers.

Crypto & Web3FintechSan Francisco, US

Brian Armstrong(CEO)inFred Ehrsam(Board Of Directors)inEmilie Choi(President & COO)inAlesia Haas(Chief Financial Officer)inPaul Grewal(Chief Legal Officer & Secretary)inLawrence (L.J.) Brock(Chief People Officer)

Co-investors1confirmationA.Capital Venturesa16z cryptoAcrew CapitalAdventure FundAndreessen Horowitz+97 more

Compass Therapeuticscompasstherapeutics.comin𝕏NASDAQ: CMPXSeries A · Dec 2017 · $49M

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)inErrik Anderson(Executive Officer, Director)inThomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsAlumni VenturesBioBritForesite CapitalGV (Google Ventures)OrbiMedvenBio Partners+3 more

Cytek Biosciencescytekbio.comin𝕏NASDAQ: CTKBOct 2020

Cytek Biosciences develops high-parametric analytical instruments and software that enable scientists at pharmaceutical companies, contract research organizations, and academic institutions to generate and analyze biological datasets.

BiotechDeep TechHardwareHealthtechMedical DevicesBellevue, US

Wenbin Jiang, Ph.D.(CEO and Chairman of the Board; co-founder)Wenbin Jiang(Executive Officer, Director)inMing Yan, Ph.D.(Chief Technology Officer; co-founder)Ming Yan(Executive Officer, Director)inJiecheng Zhang(Director)Allen Poirson(Director)

Co-investors3E Bioventures CapitalNorthern Light Venture CapitalRA Capital

Denali Therapeuticsdenalitherapeutics.cominNASDAQ: DNLISeries A · Feb 2024 · $220M

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Marc Tessier-Lavigne(Founder)inAlexander O. Schuth(Executive Officer)inRyan J. Watts(President, Chief Executive Officer and Director)inCarole Ho(Executive Officer)inSteve E. Krognes(Director)inAlexander Schuth(Founder)

Co-investorsARCH Venture PartnersEcoR1 CapitalForesite CapitalGV (Google Ventures)Flagship PioneeringFlagship Ventures

Flywireflywire.comin𝕏NASDAQ: FLYW

Flywire is a global payments platform and software company that enables complex international payments across education, healthcare, travel, and B2B sectors.

Enterprise SoftwareFintechSaaSBoston, US

Iker Marcaide(Founder)inMike Massaro(Founder)inRob OrgelinMike Massaro (CEO)(Founder)

PartnerDavid Jegen· led

Co-investors3Spoke Capital500 GlobalAccelBain Capital VenturesBalderton CapitalBoston Seed Capital+10 more

Insmedinsmed.comin𝕏NASDAQ: INSM

Insmed is a biopharmaceutical company that provides grants and charitable funding to support healthcare provider education and patient care initiatives focused on nontuberculous mycobacterial lung disease, non-cystic fibrosis bronchiectasis, and other serious lung diseases.

BiotechDigital HealthHealthtechMedical Devices

Will Lewis(Chair and Chief Executive Officer)inGeoffrey AllaninSara Bonstein(Chief Financial Officer)inRoger Adsett(Chief Operating Officer)Martina Flammer(Chief Medical Officer)inS. Nicole Schaeffer(Chief People Strategy Officer)in

Co-investorsBessemer Venture PartnersForesite CapitalHercules Capital, Inc.OrbiMedProspect Venture PartnersRidgeback Capital+1 more

Pony.aipony.aiin𝕏NASDAQ: PONY

Pony.ai develops autonomous driving technology and systems for multiple applications including robotaxis, robotrucks, and personally owned vehicles, serving both everyday mobility and commercial logistics markets.

AI & Machine LearningMobility & TransportationRoboticsSilicon Valley, US

James Peng(Founder)inTiancheng Lou(Founder)inJames Peng Tiancheng Lou(Founder)

Co-investors5Y CapitalComcast VenturesComet LabsDCM VenturesHongShan Capital GroupTeachers' Venture Growth+3 more

Precision BioSciencesprecisionbiosciences.comin𝕏NASDAQ: DTIL

Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

BiotechDeep TechHealthtechDurham, US

MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)inDerek Jantz(Co-founder)inTODD MELBY(Executive Officer)inMichael Amoroso(President, Chief Executive Officer)in

BoardROBERT ADELMAN(Director)

Co-investorsage1Agent CapitalAliment CapitalBrace PharmaOCV PartnersOUP (Osage University Partners)+6 more

Prime Medicineprimemedicine.comin𝕏NASDAQ: PRMESeries A · Oct 2019 · $120M

Prime Medicine develops one-time genetic therapies using Prime Editing, a gene editing technology developed in David R.

BiotechDeep TechHealthtechMedical Devices

Andrew Anzalone(Founder)inDavid Liu(Co-founder)inAllan Reine(Chief Executive Officer)inMohammed Asmal(Chief Medical Officer)inAnn Lee(Chief Technical Officer)inSvetlana Makhni(Chief Financial Officer)in

Co-investorsARCH Venture PartnersGV (Google Ventures)Newpath PartnersOUP (Osage University Partners)Samsara BioCapitalArrive+1 more

Rallybio, LLCrallybio.comin𝕏NASDAQ: RLYB

Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.

BiotechHealthtechNew Haven, US

Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)

Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsMitsui Global InvestmentPivotal Life SciencesSolasta Ventures+2 more

Toasttoasttab.cominNYSE: TOST

Toast provides a restaurant management platform combining point-of-sale hardware (Flex POS, Toast Go 3 handheld) with software tools for online ordering, payroll, and other operations.

FintechFoodTechRetail TechSaaSBoston, US

Stephen Fredette(Executive Officer, Director, Promoter)Jonathan Grimm(Founder)inAman Narang(Founder)inChristopher Comparato(Executive Officer, Director)Steve Fredette(Founder)

BoardSteve Papa(Director, Promoter)

PartnerDavid Jegen· led

Co-investorsBessemer Venture PartnersBlue Owl CapitalConnetic VenturesEvolution VC PartnersFIRSTFLOOR CAPITALG2C Venture Partners+15 more

Unum Therapeuticscogentbio.comin𝕏NASDAQ: COGT

Cogent Biosciences is a biotechnology company developing small molecule precision therapies for genetically driven diseases where the cause is linked to a specific genetic mutation.

BiotechDigital HealthHealthtechLongevityMedical DevicesCambridge, US

Charles Wilson(Executive Officer, Director)Christiana Stamoulis(Executive Officer)inAndrew Robbins(Chief Executive Officer, President and Director)inJohn Green(Chief Financial Officer)inEvan Kearns(Chief Legal Officer and Corporate Secretary)inCole Pinnow(Chief Commercial Officer)in

Co-investorsAtlas VentureSanofi Ventures

Eywa Pharmaeywapharma.sgOct 2016 · $30M✓ verified

Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies.

Advanced ManufacturingBiotechHealthtechMedical DevicesSingapore, SG

BoardKetan Patel(Director)in

Leyden Labsleydenlabs.cominSeries A · Mar 2021 · $47M✓ verified

Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.

BiotechDeep TechHealthtechLeiden, NL

Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in

Co-investorsClavystBioGV (Google Ventures)Bluebird VenturesByers CapitalCasdin CapitalEuropean Innovation Council Fund+7 more

Nflection Therapeuticsnflection.cominJul 2023✓ verified

NFlection is a biopharmaceutical company developing novel therapeutics.

BiotechMedical DevicesBoston, US

Christopher Powala(Chief Development Officer, Former President & CEO)Mark de Souza(Executive Officer, Director)in

BoardCorey Goodman(Director)Ketan Patel(Director)in

Co-investorsvenBio PartnersvenBio Global Strategic

OrsoBioorsobio.comin𝕏✓ verified

OrsoBio develops therapies to restore energy homeostasis in patients with severe metabolic disorders, drawing on biological research including human liver organoids and insights from metabolic pathways.

BiotechDeep TechMedical DevicesMenlo Park, US

Mani Subramanian(Executive Officer, Director)inGangadhara Ganapati(Executive Officer, Director)Dr. SubramanianDr. Myers

BoardMatthew Young(Director)inSrinivas Akkaraju(Director)

Co-investorsAscenta CapitalLongitude CapitalSamsara BioCapital

1Uphealth1up.healthin𝕏Series B · Apr 2023 · $25M

1upHealth provides a FHIR-first health data platform that helps health plans and payers acquire, manage, and exchange healthcare data, including automating prior authorization, member data access, and provider directories.

Data & InfrastructureDigital HealthHealthtechBoston, US

Ritwik Sahu(Executive Officer, Director)Ricky Sahu(Founder)inJoseph Gagnon(Director)Andrew Boyd(Chief Executive Officer)in

BoardVictor Echevarria(Director)inDavid Jegan(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsEniac VenturesJackson Square VenturesMeridian Street CapitalSixth StreetSocial Leverage

Affinia Therapeuticsaffiniatx.cominSeries A · Oct 2025 · $60M

Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions.

AI & Machine LearningBiotechDeep TechWaltham, US

Luc Vandenberghe(Director)Aaron Tward, M.D., Ph.D.(Scientific Co-Founder)Botond Roska, M.D., Ph.D.(Scientific Co-Founder)Luk Vandenberghe, Ph.D.(Scientific Co-Founder and Adviser, and Board Member)Rami Daoud(Executive Officer)inRick Modi(Chief Executive Officer, Board Member)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAtlas VentureEcoR1 CapitalEight Roads VenturesGV (Google Ventures)New Enterprise Associates (NEA)TCG Crossover

Antlia Bioscience, Inc.antliabio.cominJun 2026SEC filingmedium confidence

Antlia Bioscience develops long-acting therapeutics aimed at treating chronic cardiometabolic diseases.

BiotechEncinitas, US

Brian Laurence Johnson(Executive Officer, Director)Ankit Mahadevia(Executive Officer, Director)

BoardBen Auspitz(Director)Carlos Garcia Echeverria(Director)

Board seatMartin TaylorNihal Sinha· per SEC Form D · $20M raise · filed Jun 2026

Buoy Healthbuoyhealth.comin𝕏Nov 2020

Buoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers.

AI & Machine LearningDigital HealthHealthtechBoston, US

Andrew Le(Founder)inAdam Lathram(Executive Officer, Director, Promoter)Jose Eduardo Reyes(Director)Nathanael Yu Ren(Director)

Board seatCarl Byers· per SEC Form D

Co-investorsEvolution VC PartnersTorch CapitalFundRxHumanaOptum VenturesTrustbridge Partners+1 more

CHARM Therapeuticscharmtx.cominSeries A · Apr 2023 · $50M

CHARM is a biotech company developing a next-generation menin inhibitor for acute myeloid leukemia (AML), designed to address resistance seen with first-generation approaches.

AI & Machine LearningBiotechHealthtechLondon

Lakshyaditya Singh Aithani(Executive Officer, Director)David Baker(Founder)Laksh Aithani(Founder)

BoardRishi Gupta(Director)inMuzammil Mansuri(Director)in

Board seatMuz MansuriNihal Sinha· per SEC Form D

Co-investorsNew Enterprise Associates (NEA)NVIDIAOrbiMedSR One Capital ManagementAxial VCKhosla Ventures+1 more

Checkmate Pharmaceuticalscheckmatepharma.comSeries B · Aug 2019 · $27MAcquired

Activating the immune system to recognize and destroy tumor cells.

BiotechCambridge, US

Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsDecheng CapitalLongitude CapitalSofinnova VenturesNovo HoldingsvenBio Partners

Comanche Biopharmacomanchebiopharma.cominJan 2024 · $75M

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women.

BiotechFemTechHealthtechConcord, US

Mike Young(Founder)inT Scott Johnson(Founder)inPaul Antinori(Executive Officer)Allison August(Executive Officer)inThomas Scott Johnson(Executive Officer, Director)

BoardBrendan Bulik-Sullivan(Director)in

Board seatMuz MansuriKetan Patel· per SEC Form D

Co-investorsAtlas VentureGV (Google Ventures)Broadview VenturesLilly Asia VenturesNew Enterprise Associates (NEA)

Ensomaensoma.comSeries A · Jan 2023 · $50M

Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.

BiotechHealthtechMedical DevicesBoston, US

Albert Seymour(Director)

BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)

Board seatStephen Knight· per SEC Form D

Co-investors5AM VenturesAju IB InvestmentCatalio Capital Management, LPDelos CapitalSolasta VenturesViking Global+10 more

Generation Biogenerationbio.comFeb 2018SEC filingmedium confidence

BiotechCambridge, US

Geoff McDonoughy(Executive Officer, Director)Glenn Goddard(Executive Officer)Mark Angelino(Executive Officer)

BoardJason Rhodes(Director)inAnthony Quinn(Director)

Board seatCatherine Stehman-Breen· per SEC Form D · $100.4M raise · filed Mar 2018

Co-investorsAtlas VentureForesite CapitalWellington ManagementCasdin CapitalDeerfield Management CompanyFidelity Investments+1 more

Notabenenotabene.idin𝕏Series A · Jun 2026 · $10.2M

Notabene provides compliance and regulatory technology for crypto businesses and financial institutions, helping them meet regulatory requirements like the FATF Crypto Travel Rule through real-time screening, sanctions checks, and wallet identification.

Crypto & Web3CybersecurityEnterprise SoftwareFintechNew York City, US

Pelle Braendgaard(CEO)inAndres Junge(Founder)inAnia Lipinska(Founder)inAlice Nawfal(Founder)inCalvin K(Head of People Operations)Sacha Lowenthal(Head of Marketing)

Board seatDavid Jegen· per SEC Form D

Co-investorsBlockchain CoinvestorsDigital Currency GroupGaingelsNextBlockParaFi CapitalParafi General Fund+17 more

OneAdvisoryoneadvisory.coJul 2025 · $8M

Dispatch is a data orchestration platform for the wealth advisory ecosystem that automatically syncs client data across disparate software tools and integrations.

AI & Machine LearningData & InfrastructureFintechSaaSMiami, US

Robert Nance(Executive Officer, Director, Promoter)Madalyn Armijo(Director, Promoter)

BoardChris Downer(Director)inRafi Lurie(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsExpaGreat Oaks Venture CapitalBrewer Lane VenturesCoFound Partners VentureFika VenturesRitholtz Wealth Management+2 more

Rarecyterarecyte.comJul 2023 · $24M

Seattle, US

Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)inJoseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)

BoardRobert Shepler(Director)in

Board seatRobert Weisskoff· per SEC Form D

Co-investors5AM VenturesArboretum VenturesTelegraph Hill PartnersHealthQuest CapitalSofinnova Ventures

Real Estate Equity Exchangeunisonim.comMay 2018SEC filingmedium confidence

Unison Investment Management (UnisonIM) is a registered investment adviser that builds and manages institutional equity and credit strategies giving exposure to U.S. residential housing and home price appreciation.

FintechPropTechSan Francisco, US

Thomas Sponholtz(Founder, CEO & Chairman)John Martinez(Director)Edgar Green(Director)James Riccitelli(Executive Officer, Director)Douglas H. Lowrey(Director)Matthew O'Hara(Chief Investment Officer)

Board seatDavid Jegen· per SEC Form D · $40M raise · filed Jun 2018

Snapdocssnapdocs.comin𝕏Seed · May 2021

Snapdocs automates the digital mortgage closing process by connecting lending, settlement, and secondary market teams.

AI & Machine LearningFintechLegalTechPropTechSaaSPortland, US

Aaron King(CEO)inMatt Schindel(Executive Officer)Sanam Pangali(Executive Officer)Michael Sachdev(CEO)inNeel Palrecha(Vice President Engineering)inPeter Clark(Head of Product)in

Board seatDavid Jegen· per SEC Form D

Co-investors137 VenturesAccelerator VenturesAlkeon InnovationMetaPropMetaProp VenturesRed Swan Ventures+20 more

Tempest Therapeuticstempesttx.cominSeries B · Feb 2020 · $70M

Tempest Therapeutics is a clinical-stage biotechnology company developing in vivo CAR-T cell therapies for autoimmune and oncology indications.

BiotechHealthtechBrisbane, US

Stephen Brady(Director)inMatthew Angel(Executive Officer, Director)Nicholas Maestas(Executive Officer)inThomas W. Dubensky, Jr.(Executive Officer, Director)Thomas Woiwode(Director)Geoffrey Nichol(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsLAVLilly Asia VenturesNew Enterprise Associates (NEA)Quan CapitalRoche Venture FundVersant Ventures

Threat Stackthreatstack.cominSep 2017 · $45M

CybersecurityBoston, US

Jennifer M. Andre(Executive Officer)Dustin Webber(Director)Brian Ahern(Executive Officer, Director)inDoug Cahill(Executive Officer, Director)in

BoardChristopher P. Lynch(Director)Maria Cirino(Director)in

Board seatGaurav Tuli· per SEC Form D

Co-investors.406 Venturesfama Ventures, LLCScale Venture PartnersTechstarsVenture Investment AssociatesAccomplice+1 more

Tradiertradier.cominSeries A · Apr 2023 · $24.6M

Tradier offers REST-based APIs and trading platforms providing equity, options, and futures trading, account management, market data, and brokerage services for individual developers and businesses.

FintechSaaSCharlotte, US

Dan Raju(Executive Officer, Director)inPeter Laptewicz(Executive Officer, Director)inRobert Kopple(Director)

BoardAlec Petro(Director)

Board seatDavid Jegen· per SEC Form D

Co-investorsDevonshire Investors

Tripsuitetripsuite.cominSeed · Sep 2024 · $5M

TripSuite is a software platform for travel agencies that combines CRM, commission tracking, accounting, itinerary management, analytics, and workflow automation in one system.

SaaSTravel & HospitalityBrooklyn, US

Jacey Jones(Executive Officer, Director, Promoter)inChristopher John Graves(Executive Officer, Director, Promoter)

Board seatGaurav Tuli· per SEC Form D

Viewrayviewray.comin𝕏Dec 2014

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment.

HardwareHealthtechMedical DevicesOakwood Village, US

James F. Dempsey(Executive Officer, Director)inDavid Chandler(Mr. Chandler is the Chief Financial Officer of the Issuer.)Chris A. Raanes(Executive Officer, Director)Michael Brandt(Executive Officer)D. David Chandler(Executive Officer)Gregory M. Ayers(President and Chief Executive Officer of the Issuer.)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAisling CapitalXeraya CapitalOrbiMed

Zenflowzenflow.comin𝕏Series B · Nov 2024 · $31.4M

Zenflow develops medical devices for treating benign prostatic hyperplasia (BPH) in men, founded from the Stanford Byers Center for Biodesign with a team experienced in medical device development and FDA regulation.

HealthtechMedical DevicesSan Francisco, US

Shreya Mehta(CTO)inNick Damiano(CEO)inJohn Beck(Executive Officer)in

BoardBryan Kim(Director)Blayne Roeder(Director)

Board seatRobert Weisskoff· per SEC Form D

Co-investorsAstiaCloudStone CapitalDorm RoomShangBay Capital LLCY CombinatorAgrolimen Ventures+15 more

Zus Healthzushealth.comin𝕏Mar 2023

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

Cloud ComputingData & InfrastructureDigital HealthHealthtechWatertown, US

Jonathan Bush(CEO)inTravis Smith(Executive Officer)inJonathan S. Bush(Founder)

BoardSteven Fisher(Director)Fay Rotenberg(Director)Julie Yoo(Director)in

Board seatCarl Byers· per SEC Form D

Co-investorsAdvection Growth CapitalAlumni VenturesAndreessen HorowitzJAZZ Venture PartnersMartin VenturesMaverick Ventures+1 more

1Money1moneynetwork.comin𝕏

1Money builds a decentralized payment network for stablecoin and tokenized deposit transfers, designed for global financial settlements.

Crypto & Web3Fintech

Matt Shroder(Founder)inBrian Shroder(Founder)inMatthew Shroder(Founder)

Co-investorsA100X VenturesCMT Digital VenturesEthereal Ventures Management Ltd.Generative VenturesHack VCPortage Ventures+5 more

3F Labs3f.xyzin𝕏

3F is a DeFi protocol for leveraged strategies on tokenized real-world assets and onchain credit, letting users take leveraged exposure to RWA vaults or deposit stablecoins into Morpho-powered lending vaults to earn yield.

Crypto & Web3Fintech

Romeo Ravagnan(Founder)in

Co-investorsMaven 11Gate VenturesGSRMetalayer

66 Nao66nao.com

脑动极光 (66nao) develops medical-grade digital therapeutics that combine brain science with AI to assess and treat cognitive impairment caused by vascular disease, neurodegenerative disease, psychiatric disorders, and childhood developmental deficits.

AI & Machine LearningDigital HealthHealthtechMental Health

蔡龙军(首席技术官兼首席运营官、代理首席执行官兼代理首席研发官 (CTO & COO, Acting CEO & Acting CRDO))王俊杰(首席财务官及联席公司秘书 (CFO & Joint Company Secretary))赖知远(市场及运营副总裁 (VP of Marketing and Operations))谭铮(董事会主席、执行董事兼首席战略官 (Chairman & Chief Strategy Officer))

ABio-Xabio-x.comin𝕏

ABio-X is a life sciences incubation platform that creates and invests in biotech and pharmaceutical companies developing innovative medicines and technologies.

BiotechDeep TechHealthtechBoston, US

Co-investorsCBC Group

Abk Biomedical Incabkbiomedical.comin𝕏Series B · Apr 2019 · $30M

ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.

BiotechHealthtechMedical DevicesHalifax, CA

Robert Abraham(Co-founder (Interventional Radiologist, MD))inDaniel Boyd(Co-founder (Material Scientist))inSharon Kehoe(Co-founder (Material Scientist))inAnthony Headley(Executive Officer)inGary Donofrio(Executive Officer)inMichael Mangano(Executive Officer, Director)in

Co-investorsEight Roads VenturesFirst Angel Network Association (FAN)Vivo Capital

Acacia Pharmaeagleus.cominSeries B · Sep 2013 · $24M

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

BiotechHealthtechMedical DevicesIndianapolis, US

Co-investorsGilde Healthcare

Adcentrx Therapeuticsadcentrx.cominApr 2023

Adcentrx Therapeutics is a biotech company focused on the discovery and clinical development of antibody-drug conjugates (ADCs) for oncology.

BiotechHealthtech

Hui Li(Founder, President & CEO)in

Co-investorsEight Roads VenturesQuan CapitalDelta Capital

Adelaadelabio.comin𝕏Series A · Jun 2021 · $60M

Adela develops blood-based tests for cancer detection using epigenetics and liquid biopsy technology, aimed at helping patients and clinicians detect and act on cancer earlier.

BiotechDigital HealthHealthtechMedical DevicesFoster City, US

Daniel Diniz De Carvalho(Executive Officer, Promoter)Scott Bratman(Executive Officer, Director)inAnne-Renee Hartman(Founder)inAlan Williams(Executive Officer)inLisa Alderson(Executive Officer, Director)inPriscilla Huang(Executive Officer)in

Co-investorsDecheng CapitalOrbiMedDeerfield Management CompanyMenlo Ventures

Aera Therapeuticsaeratx.comin𝕏

Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

Feng Zhang, Ph.D.(Scientific Founder & Board Observer)Akin Akinc, Ph.D.(Chief Executive Officer & Board Director)Akin Akinc(Founder)Feng Zhang(Founder)Feng Zhang Akin Akinc(Founder)John Maraganore(Founder)

Co-investorsARCH Venture PartnersLux CapitalGV (Google Ventures)JDRF T1D FundAltitude Ventures Management, LlcNewpath Partners

Albert Inventalbertinvent.cominJun 2023

Albert provides an operating system for chemists that combines structured data management with AI trained on molecular structures and individual company chemistry datasets.

AI & Machine LearningDeep TechEnterprise Software

Zach Kisner(Co-founder)inKen Kisner(Founder)inNick Talken(Founder)inNeelesh Vaikhary(Co-founder)inZack Kisner(Founder)in

Co-investorsBlue Trail PartnersCapitalGCoatue ManagementCoral CapitalHomebrewIndex Ventures+2 more

Alderaskalder.comin

A senior care consulting firm serving Greater Boston families since 1993, offering life care management and aging support services with clinical expertise in geriatric social work.

Digital HealthHealthtechLongevityWellness & FitnessBoston, US

Kate Granigan(Clinical Leadership / Founder)in

Co-investorsHealthTrend Capital

Alfredalfredpay.ioin𝕏

Alfred Pay provides cross-border payment infrastructure for Latin America, offering virtual local bank accounts, instant multi-currency settlement, and a developer API.

Crypto & Web3FintechSaaS

Diego Yanez(Founder)in

Co-investorsDepartment of XYZDigital Currency GroupRayo Capital GroupVenture Dept.White Star CapitalHOF Capital+4 more

Alibabaalibaba.com

Alibaba.com operates a global B2B e-commerce marketplace that connects buyers with suppliers and manufacturers for wholesale products across multiple industries.

AI & Machine LearningB2B MarketplacesE-commerce

Kuo ZhanginJack Ma(Founder)

Co-investorsAcross Capital PartnersEight Roads VenturesGeneral AtlanticGranite AsiaICONIQK2 Global+9 more

Alkeon Capitalalkeon.comJul 2025

Alkeon is an investment firm that invests in growth-stage and innovative companies across their lifecycle, with a venture capital portfolio spanning multiple stages and industries.

Co-investorsAlkeon InnovationAccelGaingelsIVP (Institutional Venture Partners)Lachy GroomTiger Global Management

Alluvial Financealluvial.financeAcquired

Staking software developer behind the enterprise liquid staking protocol Liquid Collective, acquired by Galaxy Digital in December 2025.

Chicago, US

Matthew R. Leisinger(Executive Officer, Director)Mara Schmiedt(Executive Officer, Director)Evan Weiss(Executive Officer)

BoardMin Teo(Director)

Co-investorsAmbush CapitalCoinbase VenturesFenbushi CapitalFigmentNascentVariant Fund

Almanac Healthalmanac.chatin𝕏Seed · Mar 2026 · $10M

Almanac Health is a clinical AI company that builds Almanac Chat, an evidence-based platform for clinical AI use by clinicians and health systems.

AI & Machine LearningDigital HealthHealthtechDover, US

Cyril Zakka(Executive Officer, Director)

Co-investorsGeneral CatalystLightspeed Venture PartnersSoma Capital

Amber Therapeuticsamber-tx.cominSeries A · Jun 2024 · $100M

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsIntuitive VenturesLightstone VenturesNew Enterprise Associates (NEA)Oxford Science Enterprises

Amphoraamphoralogistics.cominJul 2017 · $35.5M

Amphora provides logistics services aimed at supporting business growth and operational efficiency.

E-commerceLogistics & Supply ChainSaaS

Joan Tresserras(Founder)inAdrià Cortés(Founder)in

Co-investorsBStartupLongitude CapitalBaird CapitalHBM Healthcare Investments

AmplifyMDamplifymd.cominMar 2022 · $23M

AmplifyMD offers a virtual care platform with EHR integrations, automation, embedded AI tools, and a network of remote specialists that lets hospitals and health systems expand physician capacity and add specialty services.

AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSLos Gatos, US

Anand Nathan(Founder)inMeena Mallipeddi(Founder)inMohan Mallipeddi, MD(Chief Medical Officer)inNijay Patel(Chief Technology Officer)inKurt Blasena(Chief Commercial Officer)in

BoardStephen K. Klasko(Board of Directors)

Co-investorsForerunner VenturesGreylock PartnersTau VenturesTAU VenturesMemorial Hermann Health System

Apellis Pharmaceuticalsapellis.comin𝕏acquired by Biogen · May 2026 · $5.6B

NASDAQ-listed company developing therapies for complement cascade-driven diseases in haematology, ophthalmology, and nephrology.

BiotechCrestwood, US

Pascal Deschatelets(Executive Officer)inCedric Francois(Executive Officer, Director)in

BoardGerald Chan(Director)Stephanie O'Brien(Director)Alec Machiels(Director)A. Sinclair Dunlop(Director)

Co-investorsAvoro Capital AdvisorsEMBL VenturesEpidarex CapitalKeyhorse CapitalSofinnova VenturesSolasta Ventures+1 more

AppliedVRappliedvr.ioin𝕏Series A · Mar 2021 · $29M

AppliedVR develops immersive therapeutic software using technology to deliver drug-free clinical treatments for patients.

Digital HealthHealthtechMedical DevicesLos Angeles, US

Matthew Stoudt(Co-Founder and CEO)inJosh Sackman(Co-Founder and President)in

BoardDavid Sackman(Chairman)

Co-investorsEntrada VenturesJAZZ Venture PartnersMagnetic VenturesPresence CapitalTechstarsGSR Ventures+1 more

AppsFlyerappsflyer.comin𝕏

AppsFlyer's Measurement Suite provides marketing attribution, incrementality, revenue, and optimization measurement across mobile, web, CTV, and PC & console channels.

AdTechAI & Machine LearningData & InfrastructureMarketing TechSaaS

Oren Kaniel(Founder)inReshef Mann(Founder)inReshef Man(Founder)

Co-investors10DDTCPGeneral AtlanticMagma Venture PartnersPitangoEight Roads Ventures+4 more

Apreo Healthapreohealth.cominAug 2025

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)Zack Scott(Director)inMichael A. Carusi(Director)Drew Field(Director)inDennis McWilliams(Director)in

Co-investorsIntuitive VenturesLightstone VenturesNorwest Venture PartnersStar51 Capital

Argyleargyle.comin𝕏Jan 2022

Argyle provides a verification platform that automates the collection and verification of income, employment, and asset data using consumer-permissioned, real-time data from payroll, banking, and document sources.

Data & InfrastructureFintechNew York, US

Samuel Fishman(Executive Officer, Director, Promoter)Shmulik Fishman(Founder)inDaniel Yanisse(Director)inChristopher Hansen(Executive Officer, Director)Audrius Zujus(Founder)

Co-investorsBain Capital VenturesGaingelsMana VenturesRackhouse Venture Management LpSignalFireStonewater Ventures+3 more

Arion Cancer Hospitalarioncare.cn

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers.

Digital HealthHealthtech

Arnatar Therapeuticsarnatar.comin𝕏

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics.

AI & Machine LearningBiotechDeep Tech

Dr. Xuehai Liang(Founder)Dr. Yanfeng Wang(Founder & Chief Operating Officer)

Co-investors3E Bioventures CapitalApricot CapitalEight Roads VenturesGaorong VenturesLegend StarNew Alliance Capital

ARTBIOartbio.comin𝕏Seed · Dec 2023 · $23M

ARTBIO develops alpha radioligand therapies (ARTs) for cancer treatment, designing target-and-molecule combinations intended to kill tumors while sparing healthy tissue.

BiotechHealthtechMedical DevicesOslo, NO

Roy Larsen(Scientific Co-Founder)Øyvind Bruland(Scientific Co-Founder; SAB Chairman)Margaret Yu(Chief Medical Officer)inPhilippe Dasse(Chief Technical Officer)inAmra Demirovic(Chief Human Resources Officer)inNicole Hadas(Chief Legal Officer)

Co-investorsB Capital GroupB4 CapitalSofinnova VenturesAlexandriaB CapitalOmega Funds+2 more

Artemis Healthartemishealth.comin𝕏Series B · Feb 2019 · $16M

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs.

Data & InfrastructureEnterprise SoftwareHealthtechSalt Lake City, US

Grant Gordon(Executive Officer, Director)inDallen Allred(Executive Officer, Director)inDallin Regehr(Executive Officer)in

BoardDalton Wright(Director)inJon Lim(Director)inAmbar Bhattacharyya(Director)

Co-investorsBessemer Venture PartnersKickstartPeterson VenturesValence VenturesMaverick Ventures

Artemis Healthgetartemis.comMar 2019

Artemis is an AI-native security operations platform that builds a live model of an organization's environment across identity, cloud, endpoint, and SaaS to detect, investigate, and respond to attacks autonomously.

AI & Machine LearningCybersecurityEnterprise Software

Co-investorsValence VenturesBessemer Venture PartnersHearst VenturesMaverick CapitalMaverick VenturesRose Park Advisors

Arvelle Therapeuticsangelinipharma.chin

Angelini Pharma Switzerland is the Swiss arm of a pharmaceutical company focused on brain health and epilepsy, offering prescription treatments for patients and healthcare professionals.

BiotechConsumerHealthtechZug, CH

Co-investorsAndera PartnersH.I.G. CapitalH.I.G. HealthBridge PartnersBRV Capital ManagementEQT Life SciencesH.I.G. BioHealth Partners

Ashbyashbyhq.comin𝕏Series A

Ashby is a recruiting software platform that serves as an applicant tracking system (ATS) and all-in-one hiring management tool for talent teams.

Enterprise SoftwareHR TechSaaSSan Francisco, US

Benjamin Encz(Founder)inAbhik Pramanik(Recruiter)inGhalib Suleiman(Software Engineer)inAaron Norby(Engineer)Colleen Gavaghen(Recruiter)Andy Brown(Engineer)

Co-investorsAlkeon InnovationDVCGaingelsSemperVirens Venture CapitalTodd and Rahul’s Angel FundTrail Run Capital+13 more

Astraeusastraeuswealth.comin

Astraeus is an AI-native operating platform for wealth management firms that unifies data across a firm's fragmented systems into a single governed semantic layer and ontology.

AI & Machine LearningFintechSaaS

Jon Stevenson(Founder)in

Co-investorsPlug and Play Ventures

Asymmetry Financeasymmetry.finance𝕏

Asymmetry Finance is a decentralized finance protocol that lets users borrow stablecoins (USDaf and AmpUSD) against BTC or stablecoin collateral at customizable fixed interest rates.

Crypto & Web3Fintech

Co-investorsMagnus CapitalSilvermine CapitalAvon VenturesCastle Island VenturesEcco Capitalgmjp+1 more

Atalantaatalantatx.comin𝕏Series A · Jan 2021 · $110M

Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.

BiotechDeep TechHealthtechMedical Devices

Co-investorsNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plcEQT Life Sciences

AvantStayavantstay.comin𝕏

AvantStay operates a collection of fully furnished, design-forward vacation rental homes in sought-after U.S. destinations, offering short- and long-term stays with amenities like concierge service, Wi-Fi, and smart locks.

B2B MarketplacesFuture of WorkMarketplacesPropTechTravel & HospitalityCulver City, US

Sean Breuner(Founder)inReuben Doetsch(Executive Officer, Director, Promoter)inJesse Suarez(Executive Officer)inJodi Kessler(Director)in

BoardShawn Colo(Director)Eric Wiesen(Director)in

Co-investors3L CapitalAbstract VenturesAlumni VenturesBlue Ivy VenturesBullpen CapitalConvivialité Ventures+11 more

AvenCellavencell.comin𝕏Series B · Oct 2024 · $110M

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

Andrew Schiermeier(Chief Executive Officer)in

Co-investorsNovo HoldingsBlackstone Life SciencesEight Roads VenturesNYBC Ventures

AviadoBioaviadobio.comin𝕏

AviadoBio is a gene therapy company developing adeno-associated viral (AAV) treatments for neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

BiotechDeep TechDigital HealthHealthtech

Chris Shaw(Co-Founder & Chief Scientific and Clinical Advisor)inDo Young Lee(Co-Founder)Youn Bok Lee(Co-Founder)inLisa Deschamps(Chief Executive Officer)inGraeme Fielder(Chief Operating Officer)inAlex Bloom(Chief Development Officer)in

Co-investorsAdvent Life SciencesDementia DiscoveryLifeArc VenturesMonograph Capital PartnersNew Enterprise Associates (NEA)SV Health Investors

Avidity Biosciencesaviditybiosciences.cominSeries B · Jan 2017 · $16M

Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases.

BiotechDeep TechHealthtechMedical DevicesLa Jolla, US

Troy Wilson PhD., JD(Executive Officer, Director)P. Kent Hawryluk(Executive Officer)inMark E. Davis(Director)Troy Wilson(Executive Officer, Director)in

BoardTodd Brady(Director)Michael Martin PhD.(Director)

Co-investorsAvoro Capital AdvisorsBrace PharmaFrazier Life SciencesMoore Venture Partners

Avivomedavivomed.com

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.

BiotechDeep TechHealthtechMedical DevicesRoseville, US

Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)

BoardTheresa C. Pappas(Director)Ketan Patel(Director)in

Co-investorsHatteras Venture PartnersTreo Ventures, Llc

Axle Healthaxlehealth.comin𝕏Series A · May 2025 · $10M

Axle Health provides a logistics and scheduling platform for home health care providers that optimizes clinician routing, staffing decisions, and patient coordination through real-time data and predictive forecasting.

AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaSLos Angeles, US

Adam Stansell(Founder)inConnor Hailey(Founder)Ian Arko(Head of Engineering)Andii Lee(Head of People and Talent)Alexa Sarachan(Operations Coordinator)

Co-investorsLightbankPear VCPioneerRebel FundSoma CapitalTRAC (Third Round Analytics Capital)+1 more

Axoniaxoni.comin𝕏Series B · Dec 2016 · $18MAcquired

Axoni provides a distributed ledger platform for post-trade processing and settlement in financial markets, serving institutional clients in capital markets operations.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintechSaaSNew York City, US

Greg Schvey(CEO)Jeffrey Schvey(CTO)inGreg (CEO)(Chief Executive Officer)Jeff (CTO)(Chief Technology Officer)Lindsay Drabczyk(People Operations Manager)Kristina Karcic(People)

Co-investorsAndreessen HorowitzCoatue ManagementCommunitas Capital PartnersDCVC (Data Collective)Digital Currency GroupY Combinator+16 more

Beadsbeads-hospice.jp

Beads Hospice operates a residential facility in Japan that provides palliative and end-of-life care for patients with terminal cancer, neurodegenerative diseases, and other specified conditions.

Digital HealthHealthtechLongevityWellness & Fitness福岡市, JP

Co-investorsEight Roads Ventures

Benchlingbenchling.comin𝕏Series B · Apr 2016 · $15M

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(CEO)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)Cory Liin

Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+31 more

Benchscibenchsci.comin𝕏Series B · Feb 2020 · $22M

BenchSci builds AI infrastructure for preclinical drug discovery, using machine learning that reads scientific literature to extract experimental evidence and map disease biology for biopharma R&D teams.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechToronto, US

David Qixiang Chen, PhD(Founder)inElvis Wianda(Founder)inLiran Belenzon(Founder)inTom Leung(Founder)inDavid Q. Chen(Founder)

Co-investorsInovia CapitalGeneration Investment ManagementGradient VenturesTCV500 GlobalAfore Capital+8 more

Better Life Partnersbetterlifepartners.comin𝕏Series B · Aug 2023 · $27M

Better Life Partners provides same-day medication-assisted treatment for opioid and alcohol addiction, combining counseling, community support, and medication for people in recovery.

Digital HealthHealthtechMental HealthHanover, US

Adam Groff(Executive Officer, Director)inJuliana Ekong(Executive Officer, Director)Myechia Minter-Jordan(Director)Steven Kelly(Executive Officer)

BoardYair Schindel(Director)inJon Lim(Director)in

Co-investorsAlumni VenturesaMoon.406 VenturesMaverick Ventures

Bioregenbioregenmed.com

BioRegenMed is a high-tech company developing biomedical materials for trauma repair and tissue regeneration.

BiotechMedical DevicesNew MaterialsChangzhou, CN

Co-investorsEight Roads Ventures

Bison Trailsbisontrails.co𝕏acquired by Coinbase

Crypto & Web3Developer ToolsFintechSaaSSan Francisco, US

Aaron Henshaw(Founder)Joseph Lallouz(Executive Officer, Director)Joe Lallouz(Founder)

BoardNicholas Chirls(Director)in

Co-investorsA.Capital VenturesBlockchain CoinvestorsCharge VCCollab+CurrencyConsenSys MeshGalaxy Ventures+8 more

Black Ducksynopsys.comin𝕏Aug 2014

Synopsys provides design automation tools and intellectual property for semiconductor and electronics companies to develop smart, connected devices.

Developer ToolsEnterprise SoftwareSemiconductorsBurlington, US

Doug Levin(Founder)Aart de Geus(Founder)inStephen N. Gregorio(Executive Officer)Philip B. Granof(Executive Officer)William NMN Ledingham(Executive Officer)Norman L. Shipley(Executive Officer, Director)

Co-investorsAsset Management CompanyBrightspark VenturesCrosslink CapitalDataTribeDifferential VenturesFrancisco Partners+11 more

Blackducksoftwareblackducksoftware.comin

Black Duck provides an application security testing platform that unifies SAST, SCA, DAST, IAST, and AI-powered analysis to detect and remediate software vulnerabilities, license compliance risks, and code quality issues across the development lifecycle.

CybersecurityDeveloper ToolsSaaS

Co-investorsEscalate Capital PartnersSapphire VenturesVolition Capital

Blue Rabbitbluerabbit.vetin

Blue Rabbit is an online veterinary pharmacy that integrates with practice management software to automate prescription fulfillment and patient data management.

E-commerceHealthtechMedical DevicesSaaS

Bluebird Kids Healthbluebirdkids.cominSeries A · Mar 2025 · $32M

Bluebird Kids Health provides pediatric care services with a family-centered approach.

Digital HealthHealthtech

Chris Johnson(Founder, Chief Executive Officer)inRachel Wilson(Co-Founder, Chief Operating Officer)inDr. Michael Glazier, MD(Co-Founder, Chief Medical Officer)Elizabeth Larsen(Co-Founder, Chief of Staff)in

Co-investors.406 VenturesAIFJUXTAPOSE VENTURES

Blueprint Medicinesblueprintmedicines.comin𝕏

Blueprint Medicines is a biopharmaceutical company that discovers and develops targeted medicines for patients with diseases such as gastrointestinal stromal tumor and other conditions driven by genetic changes.

BiotechHealthtechCambridge, US

Nick Lydon(Director)Christoph S. Lengauer(Executive Officer)inChristine Bellon(Executive Officer)inKyle Kuvalanka(Executive Officer)in

BoardAlexis Borisy(Executive Officer, Director)Daniel Lynch(Director)

Co-investorsForesite CapitalNextech InvestRA CapitalRidgeback CapitalWellington ManagementThird Rock Ventures

Buoybuoy.moneyAug 2017 · $6.7M

Buoy provides an embedded finance API for working capital and liquidity management, letting treasury managers request on-demand top-ups when prefunding accounts run low.

FintechSaaS

Dan Kleinbaum(CEO)

Co-investorsTimon CapitalFundRxHumanaOptum VenturesTrustbridge PartnersWR Hambrecht

Burroburro.aiin𝕏Jan 2024 · $24M

Burro builds autonomous robots for agricultural and outdoor operations that mow, tow, carry, and spray to automate manual labor tasks.

AgTechAI & Machine LearningRobotics

Terry Scott(Founder)inCharlie Andersen(Founder)Vibhor Sood(Founder)

Co-investorsAsimov VenturesCatalyst InvestorsCIBUS ENTERPRISE FUND II LPEverywhere VenturesFf Venture CapitalNextFab Ventures+6 more

Cadence Neurosciencecadenceneuro.cominMay 2023 · $26M

Cadence develops a neuromodulation system intended to be a more effective, less invasive treatment for people living with drug-refractory epilepsy.

BiotechDigital HealthHealthtechMedical DevicesSammamish, US

Kent Leyde(Executive Officer, Director, Promoter)inWarren Douglas Sheffield(Executive Officer, Director, Promoter)

Co-investorsJAZZ Venture PartnersLumira VenturesAngelini VenturesIaso VenturesMayo Clinic Ventures

Canary Technologiescanarytechnologies.comin𝕏Series A · Feb 2022 · $15M

Canary Technologies provides digital management software for hotels, replacing traditional paper-based administrative and operational workflows used across the hospitality industry.

Enterprise SoftwareSaaSNew York City, US

Harman Narula(Founder)inSJ Sawhney(Principal)inBryan Michalis(Strategic Initiatives)Stuart Moncada(Vice President Product)Blake VanLandingham(Head of engineering)

Co-investors7BC Venture CapitalBrighton Park CapitalCommerce VenturesDERIVE VENTURESG VenturesInsight Partners+13 more

Candidcandidco.comin

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

Nick Greenfield(Founder)in

Co-investorsA-Rod CorpAverin CapitalBessemer Venture PartnersBeyond CapitalFantail VenturesHanaco Venture Capital+9 more

Canoe Intelligencecanoeintelligence.comin

Canoe Intelligence provides AI-driven software and data infrastructure for alternative investment management, processing capital call notices, distribution notices, and capital account statements from institutional fund managers to deliver real-time visibility into capital flows across trillions in assets under administration.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechSaaS

Jason Eiswerth(CEO)inNoel Calhoun(CTO)in

PartnerDavid Jegen· led

Co-investorsInner Loop CapitalGoldman Sachs

Caplin Point Laboratoriescaplinpoint.netin

Caplin Point Laboratories is a pharmaceutical manufacturer that produces ointments, creams, external applications, and other formulations.

Advanced ManufacturingBiotechHealthtechChennai, IN

C.C. Paarthipan(Chairman)Sridhar Ganesan(Managing Director)in

Carestackcarestack.comin𝕏Apr 2021 · $25M

CareStack is a cloud-based, all-in-one dental practice management software covering scheduling, patient experience, clinical workflows, revenue cycle management, analytics, and compliance.

Digital HealthHealthtechSaaS

Abhi Krishna(Founder)Abhilash Krishna(Founder)Abilash Krishna(Founder)Kevin Cook(Founder)Mark Huzyak(Founder)Varun Nelson(Founder)

Co-investorsAccelCallapina CapitalEight Roads VenturesSteadview Capital

Carrot Fertilityget-carrot.comin𝕏Series C · Jun 2023

Carrot is a global fertility and family-building platform that provides access to fertility care, maternity support, and family-building guidance for individuals and families.

FemTechHealthtechHR TechSan Francisco, US

Asima Ahmad(CMO)inTammy Sun(Founder)inDavid Utley(Executive Officer, Director)Dr. Asima Ahmad(Founder)Arun VenkatesanMaxwell Radomsky

Co-investors515 VenturesAll TurtlesAurumBackstage CapitalCore Venture CapitalCRV (Charles River Ventures)+18 more

Cartesian Kineticscartesiankinetics.comin

Cartesian Kinetics develops "Physical AI" for fulfillment and warehouse operations, combining automation software and rack-native robotics that work within a facility's existing racks, systems and workflows rather than requiring a rebuild.

AI & Machine LearningHardwareLogistics & Supply ChainRoboticsSaaSSan Jose, US

Co-investorsCelesta CapitalKae Capital

Casacasa.ioin𝕏

Casa provides self-custody solutions for bitcoin and stablecoins, offering multi-signature security infrastructure for both individual and institutional users.

Crypto & Web3Fintech

Nick Neuman(Founder & CEO)in

Co-investors515 VenturesAcrew CapitalBlockchain CoinvestorsChampion Hill VenturesCoinbase VenturesFabric Ventures+11 more

Castlecastle.ioin𝕏Seed · Jan 2019

Castle builds trust infrastructure for the modern internet, helping organizations detect and prevent fraud and account takeover attacks.

CybersecurityDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Johan Brissmyr(CEO)inSebastian Wallin(CTO)inMax Nussenbaum(Founder)inScott Lowe(Founder)inTim Dingman(Founder)in

BoardShardul Shahin

Co-investorsFirst Round CapitalIndex VenturesY CombinatorFundersClubWalking VenturesBoost VC+8 more

Castlegetcastle.cominFeb 2019 · $9.2M

Castle builds payments infrastructure for homeowners, starting with a bill-pay app that helps them automate, consolidate, and reduce their household spending.

FintechPropTech

Co-investorsSuffolk TechnologiesFirst Round CapitalIndex VenturesY Combinator

Castlecastle.finance𝕏Feb 2019 · $9.2M

Castle offers a treasury yield management product that lets DAOs and other liquidity providers put their treasury assets to work in DeFi according to their risk profile.

Crypto & Web3Fintech

Co-investorsMDSV CAPITALFirst Round CapitalIndex VenturesY Combinator

Castorcastoredc.cominSeries B · Jul 2021 · $45MDefunct

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

AI & Machine LearningCloud ComputingData & InfrastructureDigital HealthHealthtechMedical DevicesSaaSTel Aviv, IL

Derk Arts(Founder)in

Co-investorsAsahi Kasei Corporate Venture CapitalInkefTechstarsChartered GroupTwo Sigma Ventures

Centivocentivo.cominSeries A · Jul 2018 · $34M

Centivo is a primary-care-centered health plan administrator for self-funded employers, sold through benefits brokers and consultants.

Digital HealthHealthtechInsurTech

Alan Cohen(Founder)inAshok Subramanian(Founder & CEO)inStuart Roth(Founder)in

Co-investorsAlumni VenturesB Capital GroupB4 CapitalBain Capital VenturesBasecamp FundCox Enterprises+7 more

Chaos Labschaoslabs.xyzin𝕏Aug 2024

Chaos Labs builds AI-driven intelligence and risk-management infrastructure that converts fragmented data into institutional-grade insights, offering risk simulations, parameter tuning, and oracle technology for crypto protocols and financial institutions.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Omer Goldberg(Founder)in

Co-investorsBalaji SrinivasanBlueYard CapitalCoinbase VenturesGalaxy VenturesHaun VenturesLightspeed Venture Partners+14 more

Charmwithcharm.appSep 2025

Charm is a payments and savings app that enables users to send money across different platforms (Venmo, Cash App, Zelle) through a unified interface, with funds earning interest when held in the app.

ConsumerCrypto & Web3FintechSocialNew York City, US

Gray Newfield(Founder)inNoah Newfield(Founder)inChristian Rocha(Founder)Toby Padilla(Founder)

Co-investorsPioneerY Combinator468 CapitalCavalry VenturesFirestreak VenturesFuel Capital+7 more

Charmcharm.land𝕏Sep 2025

Charm builds open-source tools and libraries for creating user interfaces and applications in the terminal, including command-line interface frameworks, markdown readers, and components for developers.

Developer Tools

Co-investorsBetaworksCavalry VenturesGradient VenturesLowercarbon CapitalMotive ForceNAP+5 more

Charmcharm.fi𝕏Sep 2025

Charm.fi is a decentralized finance platform offering automated liquidity management vaults on Ethereum, letting users browse or create vaults for any token and build LP strategies to manage liquidity and earn yields.

Crypto & Web3Fintech

Co-investorsCoinbase VenturesCavalry VenturesFuel CapitalGradient VenturesKhosla VenturesNew Enterprise Associates (NEA)+2 more

Cipla Healthciplahealth.inin

Cipla Health is a consumer healthcare subsidiary that sells branded over-the-counter health products including throat lozenges, cough remedies, probiotics, oral care, and wellness supplements.

ConsumerHealthtechWellness & Fitness

Cloudantcloudant.comacquired by IBM

IBM Cloudant is a managed NoSQL database service based on Apache CouchDB, designed for building hyperscale, globally distributed applications with features including encryption, multi-region availability, full-text search, and geospatial indexing.

Cloud ComputingData & InfrastructureEnterprise SoftwareBoston, US

Michael Miller(Chief Scientist)inAlan Hoffman(Director of Product)inAdam Kocoloski(CTO)inMatt HumphreyStefano J. Attardi(Designer \u0026 Front-End Developer)

PartnerDavid Jegen· led

Co-investorsAvalon Ventures Management, LlcCarbide VenturesIn-Q-TelToba CapitalY CombinatorDevonshire Investors+2 more

Clstclst.com

CLST is a Zurich-based platform for institutional crypto and stablecoin lending with automated negotiation and risk assessment.

Michael Guzik(Founder)in

Co-investorsCoinbase VenturesDigital Currency GroupSICTICTX Ventures

Codeshipcodeship.comin𝕏acquired by CloudBees

Cloud ComputingDeveloper ToolsEnterprise SoftwareSaaSBrookline Village, US

Moritz Plassnig(CEO)inSacha Labourey(Co-founder)François Déchery(Co-founder)Manuel Weiss(Executive Officer)inFlorian Motlik(Executive Officer)in

BoardJohn SImon(Director)

Co-investorsAscent Venture PartnersCamber PartnersGolub GrowthMatrixNewView CapitalRembrandt Venture Partners+4 more

Coin Metricscoinmetrics.ioin𝕏

Coin Metrics provides market and on-chain data, reference rates, and indexes for crypto and digital assets, delivered to institutional investment teams via APIs.

Crypto & Web3Data & InfrastructureFintechBoston, US

Tim Rice(Founder)inAleksei Nokhrin(Founder)Alexander Bich(Founder)Jacob Franek(Founder)

BoardMathew S. McDermott(Director)Sean Judge(Director)in

Co-investorsAcrew CapitalBlockchain CoinvestorsCoinbase VenturesCollab+CurrencyCommunitas Capital PartnersDigital Currency Group+10 more

Coincovercoincover.comin𝕏

Coincover provides encryption-based protection and recovery for crypto private keys, sharding key material across independent parties so no single provider holds a complete key.

Crypto & Web3CybersecurityFintechCardiff, GB

David J.(Founder)inDavid JanczewskiAdam Smithin

Co-investors13books CapitalFoundation CapitalInsurtech Gateway FundValor Equity PartnersDevelopment Bank of WalesElement Ventures+2 more

ConnexPayconnexpay.cominOct 2022

ConnexPay provides a payment platform that lets businesses accept customer payments and fund immediate supplier payments via virtual cards from the same transaction, closing the cash flow gap.

FintechSaaSTravel & HospitalityBonita Springs, US

Robert Kaufman(Chief Executive Officer and member of the Board of Managers)in

BoardMark Buffington(Member of the Board of Managers)inJacob Eisen(Member of the Board of Managers)Pamela Joseph(Member of the Board of Managers)Barbara Polsky(Member of the Board of Managers)

Co-investorsBIP VenturesFTV CapitalTamiami AngelBIP Capital

Core Diagnosticscorediagnostics.inin𝕏Dec 2016

Core Diagnostics offers diagnostic laboratory testing with sample collection services, including routine tests and diagnostic monitoring tests scheduled at defined intervals.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsArtiman VenturesEight Roads Ventures

Countablecountable.com

Actionable is a self-service advocacy platform that lets organizations launch, manage, and measure campaigns such as petitions, pledges, lawmaker messages, and supporter mobilization without developers or consultants.

GovTechImpact & Social GoodSaaSOakland, US

Bart Myers(Executive Officer, Director)

BoardJoydeep Bhattacharyya(Director)in

Co-investorsCanaan PartnersFernbrook Capital ManagementSilicon ValleySource Ventures

Countable Labscountablelabs.comin𝕏Series A · May 2026 · $26M

Countable Labs (formerly Enumerix) develops Countable PCR, a DNA quantification technology that provides absolute target counts at single-molecule resolution as an alternative to qPCR, digital PCR, and NGS.

BiotechDeep TechHealthtechMedical DevicesPalo Alto, US

Stephen Fodor(Co-Founder & Board Director)Ari Chaney(Co-Founder & Board Director)inChristina Fan(Co-founder + CTO)inGiovanna Prout(Chief Executive Officer)in

Co-investorsARCH Venture PartnersPrimer Ventures

Curegenix Corporationcuregenix.com

Curegenix is a clinical-stage biopharmaceutical company founded in 2009 that develops small-molecule drugs targeting the WNT signaling pathway, including lead candidate CGX1321, for cancer and tissue repair, with operations in California and Guangzhou, China.

Curie Biocurie.bioin

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

Zach Weinberg(Founder)inAlexis Borisy(Founder)Christoph Lengauer(Founder)

Co-investorsAlleyCorpARCH Venture PartnersBoxGroupDNA CapitalGV (Google Ventures)Lightstone Ventures+5 more

Curvancecurvance.com𝕏

Curvance is a decentralized finance protocol that combines depositing, borrowing, leveraging, swapping, and yield earning into a single dashboard.

Crypto & Web3Fintech

Co-investorsV3V VenturesYunt CapitalCurveFlowdeskFRAX FinanceGSR+4 more

Cyclopscyclops.ioin𝕏Jul 2026

Cyclops is a unified crypto and stablecoin platform built specifically for payments companies, combining licensing, custody, compliance, and 24/7 settlement into a single integration.

Crypto & Web3FintechSaaSMiami, US

Alex Wilson(Founder)in

Co-investorsNava VenturesCastle Island VenturesCircle & Co.Coinbase Ventures

Cyclopscyclopsmedtech.comin𝕏Jul 2026

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders.

Digital HealthHealthtechMedical Devices

Co-investorsCapria VenturesCastle Island VenturesCircle & Co.Coinbase VenturesNava Ventures

Dara5dara5.cominJun 2025

A community and investment platform that connects Gen Z and millennial entrepreneurs with venture capital and private equity opportunities in Europe and the US, offering networking, academy programs, and professional development.

Fintech

Eyal Raphael Samovich(Founder)inOliver Hardcastle(Founder)in

Co-investorsAllied Venture PartnersAMK Investment OfficeAcronym Venture CapitalAlumni VenturesSpark Capital

Dataplordataplor.comin𝕏Series B · Jun 2025 · $21M

Dataplor provides global point-of-interest, mobility, and brand location data with AI-powered analytics for investors to assess market share, growth trends, and foot traffic.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechRetail TechSaaS

Co-investorsAlumni VenturesAPA Venture PartnersBlue Ivy VenturesBlue StartupsCircadian VenturesFf Venture Capital+21 more

Deal Enginedealengine.techinNov 2022 · $5.3M

Deal Engine provides a white-labeled, AI-powered data platform that helps private equity firms and investment banks identify and progress deals in real-time by codifying coverage strategies and delivering actionable market intelligence across integrated systems.

AI & Machine LearningEnterprise SoftwareFintechSaaSLondon, GB

Phil Westcott(CEO)in

Co-investorsFINTOP Capital

Deal Enginedeal-engine.comNov 2022 · $5.3M

Deal Engine provides automated refund and change management solutions for the travel industry.

AI & Machine LearningSaaSTravel & HospitalityMiami, US

Co-investorsDorm RoomPlug and Play VenturesThayer Ventures

Debutdebutbiotech.comin

Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.

Advanced ManufacturingAI & Machine LearningBiotechConsumerSan Diego, US

Joshua Britton(Founder)inBrady Beauchamp(Founder)Greg Weiss(Founder)

BoardCain A. McClary(Director)in

Co-investorsGS FuturesMaterial ImpactBreakout VenturesKdT VenturesSandbox IndustriesACVC Partners+12 more

Devoted Healthdevoted.comSeries A · Oct 2017 · $62M

Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.

HealthtechInsurTechUnited States, US

Todd Park(Founder)inEd Park(Founder)in

BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)inKathleen Sebelius(Director)

Co-investorsAndreessen HorowitzBronze InvestmentsCapital FactoryCox EnterprisesDns CapitalDreamers VC+30 more

Dimension TherapeuticsinSeries B · Apr 2015 · $65Macquired by Ultragenyx Pharmaceutical · Oct 2017 · $152.3M

Dimension Therapeutics was a Cambridge, Massachusetts biopharmaceutical company developing AAV-based gene therapies for rare liver-associated metabolic diseases like hemophilia, OTC deficiency, and glycogen storage disease.

Cambridge, US

Annalisa Jenkins(Executive Officer, Director)

BoardBenjamin Auspitz(Director)Donald J. Hayden(Director)Allan Fox(Director)

Co-investorsNew Leaf Venture PartnersOrbiMed

Dinaridinari.comin𝕏May 2025

Dinari provides tokenized stocks and ETFs (dShares) that combine traditional equity securities with blockchain-based digital assets, serving financial institutions like neobanks, fintechs, brokerages, and institutional traders across 85+ jurisdictions.

Crypto & Web3FintechPalo Alto, US

Gabriel Otte(Executive Officer, Director)inAltay MalazgirtinJake Timothyin

Co-investors500 GlobalAlliance DAO (ex DeFi Alliance)Factor CapitalHack VCSancus VenturesSilvermine Capital+4 more

Dispatch iodispatch.ioin

Dispatch is a data orchestration platform that connects wealth technology software by automating client data collection and synchronization across advisory firm tech stacks.

Data & InfrastructureEnterprise SoftwareFintechSaaS

Rob Nance(Co-founder, CEO)inMadalyn Armijo(Co-founder, COO)inRafi Lurie(Co-founder, CPO)in

Co-investorsBrewer Lane VenturesFikaFlyover CapitalMassMutual VenturesNew York Life VenturesPerceptive Ventures Management Company, Llc+3 more

Docereedoceree.comin𝕏Series A · Sep 2023 · $35M

Doceree offers a software platform for pharmaceutical brand teams, positioned as a single "system of work" that unifies market research, HCP targeting, media planning, measurement, CRM, and MLR workflows in place of fragmented tools.

AdTechDigital HealthMarketing TechSaaSShort Hills, US

Harshit Jain(Founder & Global CEO)inKamya Elawadhi(Co-Founder & President)inPulkit Jain(VP - Finance & Investments)inVijay Adapala(Chief Business Development Officer)inThomas Shea(Chief Revenue Officer, AI and Patient Affordability Solutions)inYesh Srinivasan(Chief AI Officer)

Co-investorsAlkemi Growth CapitalEight Roads Ventures

Dust Identitydustidentity.cominJul 2019

Dust Identity develops physical identity solutions using diamond-based technology to authenticate and trace high-value products and components across supply chains.

Circular EconomyDeep TechDefense TechEnterprise SoftwareHardwareIoTNew MaterialsRetail TechNeedham, US

Ophir Gaathon(Founder)inDirk Englund(Founder)

BoardIlya Fushman(Director)in

Co-investorsAlumni VenturesAngular VenturesBlockchain CoinvestorsGrit VenturesMotier VenturesNew Science Ventures+7 more

Eaglebrook Advisorseaglebrook.comin

Eaglebrook is a crypto investment platform for wealth managers, offering tax-optimized Bitcoin, Ethereum, and multi-asset separately managed accounts (SMAs) held in segregated accounts at qualified custodians.

Crypto & Web3FintechSaaS

Christopher King(Founder)in

Co-investorsBrewer Lane VenturesHack VCAvon VenturesCastle Island VenturesFlyover CapitalFranklin Templeton+3 more

Eigen Innovationseigen.ioinAug 2026 · $20M

Eigen Innovations develops AI vision software and solutions for manufacturing enterprises to enable digital transformation and improve operational efficiency.

Advanced ManufacturingAI & Machine LearningEnterprise SoftwareHardwareFredericton

SCOTT EVERETT(Director)inPaul Scherer(Founder)inRICHARD JONES(Executive Officer, Director)inErin Barrett(Chief Executive Officer)in

BoardBILL BARRETT(Director, Promoter)RICKY DUBAY(Director)

Co-investorsCeltic House Asia PartnersEast Valley VenturesFirst Angel Network Association (FAN)Momenta VenturesAGI HOUSE VENTURESAramco Ventures+9 more

Elementuselementus.ioin

New York, US

Max Galka(Executive Officer, Director)inNuria Gutiérrez Prunera(Founder)Chris LipowiczinVladimir Jelisavcic(Director)

BoardAnthony Pompliano(Director)in

Co-investorsMoonshots CapitalParaFi CapitalVelvet Sea VenturesAvon VenturesGemini Frontier FundLightspeed Venture Partners+2 more

Eleoseleos.co.ukin𝕏Nov 2023 · $40M

Eleos offers life insurance and income protection to consumers in the UK, with an app-based process that explains cover in plain English, provides instant answers, and connects users to licensed experts by WhatsApp, email, or phone.

FintechInsurTech

Co-investorsaMoonArkin CapitalFuel VenturesHeartfelt CapitalInsurTechEight Roads Ventures+4 more

Eleos Healtheleos.healthinSeries A · Nov 2023 · $40M

Eleos develops AI-powered software that helps behavioral health clinicians deliver more effective care through data measurement and personalization.

AI & Machine LearningDigital HealthHealthtechMental HealthCambridge, US

Alon Joffe(Founder)inDror Zaide(Founder)inAlon Rabinovich(Founder)inDenny Morrison(Chief Clinical Officer)inRaz Karmi(Chief Information Security Officer)inNoam Cohen(VP of R&D)in

Co-investorsaMoonArkin CapitalArkin Digital HealthGaingelsGreenfield PartnersLool Ventures+5 more

Elucidataelucidata.ioin𝕏Series A · Sep 2022 · $16M

Elucidata is a company oriented around supporting scientific research, emphasizing making users' research more efficient and respecting the scientific method.

AI & Machine LearningBiotechData & InfrastructureCambridge, US

Abhishek Jha(Co-founder & CEO)Swetabh Pathak(Director)in

Co-investorsHyperplane Venture CapitalEight Roads VenturesIvyCap Ventures

Embarkembarkvet.comin𝕏

Embark Veterinary develops dog DNA tests and science-backed supplements for dog health and genetics.

BiotechConsumerHealthtech

Amish Desai(Chief Executive Officer)inTali Ronen(SVP, People)inGrace Carter(VP, Finance)in

Co-investorsDCVC (Data Collective)FJ LabsFounder CollectiveFundersClubPeak PartnersSlow Ventures+4 more

Engrail Therapeuticsengrail.cominSeries B · Mar 2024 · $170M

Engrail Therapeutics is a clinical-stage pharmaceutical company developing precision-targeted therapeutics for neupropsychiatric and neurodevelopmental disorders.

BiotechDigital HealthMedical DevicesSan Diego, US

Stephen(Co-founder, EVP Research & Development and Chief Development Officer)Paul Cayer(Chief Financial Officer)inVikram(President and Chief Executive Officer)Kimberly(Chief Scientific Officer)Quentin(Chief Technical Officer)

Co-investorsForesite CapitalLongwood FundNorwest Venture PartnersPivotal Life SciencesRiverVest Venture PartnersYsios Capital+4 more

Enzene Biosciences Ltdenzene.comin𝕏Jan 2023 · $50M

Enzene Biosciences is a biologics company focused on the development and manufacturing of biopharmaceuticals.

Advanced ManufacturingBiotechHealthtechMedical Devices

Co-investorsEight Roads Ventures

Equipequip.healthin𝕏Feb 2022 · $58M

Equip provides virtual care and treatment services for eating disorders through a digital platform.

Digital HealthHealthtechMental HealthCarlsbad, US

Kristina Saffran(Co-founder)inErin Parks(Co-founder, clinical psychologist)inJay Wuellner(Executive Officer)inNikia Bergan(Executive Officer, Director)inJanice Tam(Executive Officer)in

BoardJon Lim(Director)in

Co-investors.406 VenturesCoalition OperatorsGeneral CatalystOptum VenturesPLUS CapitalStripes+3 more

Eris Innovationserisfutures.comin

Eris Innovations is an intellectual property licensing company that developed and patented the Eris Methodology, a way to list exchange-traded futures replicating interest rate swaps, which it licensed to CME Group for Eris SOFR Swap futures and Eris Options.

Fintech

Michael Riddle(Chief Executive Officer)in

Co-investorsCTC VenturesChicago Trading CompanyVirtu Financial

Ethena Labsethena.fi𝕏Feb 2025

Ethena operates a crypto protocol offering USDe, a digital dollar, and sUSDe, a reward-accruing asset backed by collateralized assets with third-party attestations.

Crypto & Web3Fintech

Guy Young(Founder)in

Co-investorsAlphaLab CapitalAtaraxia CapitalBitDAOBreedCaladanCVP NoLimit+21 more

EurekaBioeurekabio.comin

EurekaBio develops technologies and solutions for the cell and gene therapy (CGT) industry, focused on treatments for diseases such as cancer, rare diseases, genetic disorders, and auto-immune conditions.

BiotechDeep TechHardwareHealthtechMedical DevicesShenzhen, CN

Co-investorsMing capital

Even Financialevenfinancial.cominSep 2019 · $18.8MAcquired

Even Financial, operating as Engine, runs a financial services marketplace and matching network that connects consumers with financial products through APIs and white-labeled experiences.

AI & Machine LearningFintechMarketplacesBrooklyn, US

Phill Rosen(Founder & CEO)Ian Rosen(Executive Officer, Director)Jarid Maged(Executive Officer, Director)

BoardBrendan Dickinson(Director)in

PartnerDavid Jegen· led

Co-investorsAAF Management Ltd.Conversion CapitalGreatPoint VenturesMassMutual VenturesValuestream VenturesCanaan Partners+6 more

Expressableexpressable.cominMay 2024 · $26M

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.

Digital HealthHealthtechSaaSAustin, US

Nicholas Barbara(Executive Officer, Director)inLeanne Sherred(President and Chief Clinical Officer)inBenjamin Pincus(Executive Officer)inSpencer Magloff(Executive Officer)inRyan Hinojosa(Executive Officer)

Co-investorsDigitalis VenturesLerer HippeauNextView VenturesHarbourVest Partners (Canada)

Eyebright Medicalebmedical.com

Eaglet Eye Medical (Aibo Medical) is a China-based manufacturer of ophthalmic medical devices covering eye surgery treatment, myopia control, and vision care.

Advanced ManufacturingHealthtechMedical DevicesBeijing, CN

Eywa Biotecheywa.bioinOct 2016 · $30M

Eywa is a team of scientists and innovators focused on advancing mental health through research and partnerships.

BiotechDeep TechDigital HealthHealthtechMental Health

Co-investorsDraper AssociatesGanesha LabGRIDXah! Ventures

FalconXfalconx.ioin𝕏

FalconX is a digital assets prime brokerage providing institutional clients with 24/7 access to liquidity and capital solutions through proprietary technology designed for risk management in volatile markets.

Crypto & Web3FintechSan Mateo, US

Raghu Yarlagadda(Founder)inAustin ReidinSuzy WaltherinBrian CristinVanessa ZhanginJoshua Limin

Co-investorsAccelAccompliceB Capital GroupB4 CapitalBlockchain CoinvestorsCleo Capital+21 more

Fazeshiftfazeshift.comin𝕏Series A · May 2026

Fazeshift provides enterprise-grade AI agents that automate accounts receivable processes for organizations, handling transaction processing, cash application, payment communications, and customer experience tasks.

AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US

Caitlin Leksana(CEO)inTimmy Galvin(CTO)in

Co-investors2048 VenturesGradient VenturesPhoenix FundPioneerRitual CapitalWayfinder Ventures+2 more

Figment Networksfigment.ioin𝕏

Figment is an independent provider of staking infrastructure, offering non-custodial staking, reward tracking, API integrations, and slashing protection to institutional clients such as asset managers, exchanges, wallets, foundations, and custodians.

Crypto & Web3Data & InfrastructureEnterprise SoftwareFintech

Lorien Gabel(Founder)inAndrew Cronk(Founder)Matt Harrop(Founder)Ryan Funduk(Founder)

Co-investors10SQ Capital (TenSquared)10T Fund3cubed VenturesAppWorks VenturesArchetypeB Capital Group+23 more

Firefly Healthfireflyhealth.cominSep 2019 · $10.2M

Firefly Health provides virtual primary care through dedicated care teams that include primary care physicians, nurse practitioners, health guides, nurses, and behavioral health specialists.

Digital HealthHealthtechInsurTechMental HealthWellesley, US

Jeff Greenberg(Founder)inJustin Dangel(Executive Officer, Director)inFay Rotenberg(Executive Officer, Director)inShirley Mills(Executive Officer)

BoardJonathan James Bush(Director)

Co-investorsAndreessen HorowitzEast 11 VenturesFloating PointGaingelsMaC Venture CapitalOak HC/FT+3 more

Flipside Cryptoflipsidecrypto.com

Edisyl builds a semantic layer that encodes organizational understanding of data meaning, metrics definitions, and institutional knowledge to enable enterprise AI tools to answer questions aligned with business logic.

AI & Machine LearningData & InfrastructureEnterprise Software

Jim Myers(Founder)in

Co-investorsBoston Seed CapitalCoinbase VenturesConvergeGalaxy VenturesM13The Chernin Group (TCG Crypto)+15 more

Flourish Healthflourish.healthSeries A · Jul 2026 · $26M

Flourish Health provides in-home mental health care for young people with serious psychiatric needs, combining clinical expertise with technology to deliver evidence-based treatment through multidisciplinary care teams.

Digital HealthHealthtechMental HealthNorth Carolina, US

Natalia Birgisson(CEO and Co-Founder)John Haskell(Co-Founder and President)Josh Gachnang(Co-Founder and Chief Technology Officer)

Co-investors25MadisonAcumen AmericaAV8 VenturesB Capital GroupCity LightGratitude Railroad+5 more

Funnelfunnel.ioin𝕏

Funnel is an AI-native marketing data platform that aggregates, models, and governs marketing data from 600+ sources into a single layer, then adds measurement and reporting on top.

AI & Machine LearningData & InfrastructureMarketing TechSaaSStockholm, SE

Fredrik Skantze(Founder)Mike O'Toole(Founder)Per Made(Founder)

Co-investorsBalderton CapitalIndustrifondenNavisionGroupOxxRET VenturesTrinity Ventures+4 more

FutureAdvisorfutureadvisor.comacquired by BlackRock

FutureAdvisor provides digital wealth management services to middle- and upper-middle-income households, offering automated portfolio management and financial advice at lower costs than traditional advisory firms.

FintechSan Francisco, US

Bo Lu(CEO)inChris Nicholson(Head of Communications \u0026 Recruiting)inJon Xu(President)in

PartnerDavid Jegen· led

Co-investorsBling CapitalCanvas VenturesGreat Oaks Venture CapitalKapor CapitalY CombinatorAgrolimen Ventures+2 more

Galatea Biogalatea.bioAug 2024 · $8M

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

Carlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

BoardWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCEI VenturesCitta CapitalFounder CollectiveFunction VenturesHelios Digital VenturesLifeX Ventures+4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Amphora MedicalBasecamp BioEmbark Veterinary, Inc.Parrot Technologies Inc / DEAbelian TherapeuticsAccuri CytometersAerium TherapeuticsAirespaceAkriveia TherapeuticsAlphagen TherapeuticsAlphaGen TxB One OrthoBang Er MedicalBetter Life MedicalBikam PharmaceuticalsBioconnect SystemsBiopaletteBTP AutomationCanoeCardiokineCitrine MedicineCogent BiosciencesDigital Assets DataFarapulseFcb HealthFoldrxFoldRx Pharmaceuticals

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.